• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17290 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal membrane oxygenation for out-of-hospital cardiac arrest]
2021     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home enteral nutrition in older patients with severe protein-energy malnutrition after hip fracture]
2021     Ontario Health Extracorporeal shockwave therapy for Peyronie's disease
2021     Ontario Health Blue light (fluorescence) cystoscopy with hexaminolevulinate hydrochloride in non-muscle bladder cancer
2021     Ontario Health Internet-delivered cognitive behavioral therapy for post-traumatic stress disorder and acute stress disorder
2021     Ontario Health iStent for people with open angle glaucoma
2021     Ontario Health DPYD genotyping in patients with cancer treated with fluoropyrimidines
2021     Ontario Health Multi-gene pharmacogenomic testing to guide medication selection for people with major depression
2021     Ontario Health Molecular testing for thyroid nodules with atypical cells of indeterminate significance
2021     Ontario Health Nonthermal minimally invasive treatments for varicose veins
2021     Ontario Health Prostatic artery embolization for benign prostatic hyperplasia
2021     Ontario Health Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2021     Ontario Health Repetitive transcranial magnetic stimulation (rTMS) for people with treatment-resistant depression
2021     Ontario Health Pigmented lesion assay for suspected melanoma lesions
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the SpaceOAR hydrogel rectal spacer during prostate radiotherapy]
2021     Ontario Health Use of B-type natriuretic peptide and N Terminal-pro B-type natriuretic peptide as diagnostic tests in people with suspected heart failure
2021     Ontario Health Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2020     Technology Assessment at SickKids (TASK) Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the pandemic
2020     Norwegian Institute of Public Health (NIPH) Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020     Norwegian Institute of Public Health (NIPH) Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020     Norwegian Institute of Public Health (NIPH) Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endovascular treatment of varicose veins by radiofrequency ablation or cyanoacrylate closure]
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Swiss Federal Office of Public Health (FOPH) Olmesartan Mono- and Combination Therapies in Patients with Essential Hypertension
2020     Swiss Federal Office of Public Health (FOPH) Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitors
2020     Swiss Federal Office of Public Health (FOPH) Chondroitin Sulfate in Osteoarthritis
2020     Swiss Federal Office of Public Health (FOPH) Iron Therapy for Iron Deficiency without Anemia
2020     NIHR Health Technology Assessment programme Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
2020     NIHR Health Services and Delivery Research programme The effects of interoperable information technology networks on patient safety: a realist synthesis
2020     NIHR Health Services and Delivery Research programme Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2020     NIHR Health Technology Assessment programme Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (relapsing remitting multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Caplacizumab (acquired thrombotic thrombocytopenic purpura) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Venetoclax (chronic lymphocytic leukaemia) - Addendum to Commission A20-39]
2020     NIHR Health Technology Assessment programme Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osilodrostat (endogenous Cushing syndrome) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darolutamide (prostate cancer) - Addendum to Commission A20-43]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Onasemnogene abeparvovec (spinal muscular atrophy) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code] Book V
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Upadacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Givosiran (acute hepatic porphyria) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin glargine/lixisenatide (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Venetoclax (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V – rapid report]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Urinary proteome analysis for detection of diabetic nephropathy in patients with diabetes mellitus and arterial hypertension. Update of Commission D13-01. - Rapid Report]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avelumab (metastatic Merkel cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Ceftolozane/tazobactam (acute pyelonephritis) - Benefit assessment according to §35a Social Code Book V
2020     NIHR Health Technology Assessment programme Non-contact infrared thermometers for measuring body temperature in acutely ill children: a method comparison study
2020     NIHR Health Services and Delivery Research programme Effects of increased distance to urgent and emergency care facilities resulting from health services reconfiguration: a systematic review
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobicistat (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Ceftolozane/tazobactam (hospital-acquired pneumonia) - Benefit assessment according to §35a Social Code Book V
2020     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid review: alternatives to timolol for the treatment of glaucoma]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update 12 months follow-up: Nusinersen in spinal muscular atrophy ("late onset") in children and adolescents ≥ 6 years
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Leadless pacemaker for right ventricle pacing (Update 2020)
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Extracorporeal cytokine haemadsorption therapy in patients with sepsis or SIRS. Update 2020
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure
2020     Ontario Health Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Intrauterine ultrasound-guided transcervical radiofrequency ablation
2020     Center for Drug Evaluation (CDE) The health technology assessment of bipolar TURP, bipolar TUVP (vaporization of the prostate), Green Light TM, thulium, holmium, and diode laser prostatectomy in Taiwan
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency-Induced Intravesical Chemohyperthermia for Non-Muscle-Invasive Bladder Cancer
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Summary: investigation, treatment and follow-up algorithm - lung cancer]
2020     Ontario Health Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2020     Ontario Health Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Health Services Research in Oncology. Part I: End-of-Life Care
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 1; Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020) Part 2 (Appendix)
2020     Ontario Health 10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020     Ontario Health Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020     Austrian Institute for Health Technology Assessment (AIHTA) Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria
2020     Ontario Health Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020     Adelaide Health Technology Assessment (AHTA) Discussion paper on pan-tumour biomarker testing to determine eligibility for targeted treatment.
2020     Ontario Health 5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with yellow fever vaccination
2020     Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with oral cholera vaccination
2020     Ontario Health Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: safety of switching biologics and their interchangeability]
2020     Health Technology Wales (HTW) The clinical effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis
2020     NIHR Health Services and Delivery Research programme Understanding and improving experiences of care in hospital for people living with dementia, their carers and staff: three systematic reviews
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of the systematic review of the effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus infections in children]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
2020     Austrian Institute for Health Technology Assessment (AIHTA) Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]